Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Hepcinat Plus Tablet
Manufacturer/Marketed By : Natco Pharma Ltd
$198.32 $154.69
Hepcinat Plus Tablet is an effective antiviral medication that combines Daclatasvir (60 mg) and Sofosbuvir (400 mg) to combat chronic hepatitis C, a serious viral infection affecting the liver in...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Daclatasvir 60 mg+ Sofosbuvir 400 mg
Active Pharmaceutical Ingredient
Hepcinat Plus Tablet
198,32$
154,69$
Hepcinat Plus Tablet is an effective antiviral medication that combines Daclatasvir (60 mg) and Sofosbuvir (400 mg) to combat chronic hepatitis C, a serious viral infection affecting the liver in adults. This powerful combination works by inhibiting the replication of the hepatitis C virus, ultimately helping to reduce the viral load and promote liver health. Patients should be aware that Hepcinat Plus may cause side effects such as fatigue, headache, or nausea, and it is essential to discuss any pre-existing health conditions or medications with a healthcare provider before starting treatment. This medication is designed for use under medical supervision, ensuring that individuals receive appropriate monitoring throughout their therapy. It is crucial for patients to adhere to the prescribed regimen to maximize the effectiveness of the treatment. By taking Hepcinat Plus, individuals can significantly improve their chances of achieving a sustained virologic response, which is the goal in managing hepatitis C. This innovative treatment option is revolutionizing the approach to hepatitis C care, paving the way for better health outcomes in affected patients. Always consult with a healthcare professional to determine if Hepcinat Plus is the right choice for your hepatitis C management plan.
Active Pharmaceutical Ingredient
Uses
• Treatment of chronic hepatitis C virus (HCV) infection
Benefits
Daclatasvir is a direct-acting antiviral medication that works by inhibiting a protein called NS5A, which is essential for the replication of the hepatitis C virus. Sofosbuvir is another direct-acting antiviral medication that works by inhibiting a different protein called NS5B, which is also essential for the replication of the hepatitis C virus. These are used to increase its effectiveness in treating HCV.
Side Effects
Hepcinat plus tablet cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Headache
• Fatigue
• Nausea
• Diarrhea
• Difficulty sleeping
Common Side Effects
• Liver problems (such as elevated liver enzymes or liver failure)
• Allergic reactions (such as rash or difficulty breathing)
• Abnormal heart rhythms
How To Use
Take Hepcinat plus tablet exactly as prescribed by your doctor. The recommended dose and dosing schedule may vary depending on your medical condition, age, weight, and other factors. It should be taken with food. Swallow the tablet as a whole with a glass of water. Patients should not chew, crush, or break the tablet, as this may affect the effectiveness of the medication. Avoid doubling the dose to compensate for the missed dose.
Safety Advice
• Breast Feeding: It is unknown if Hepcinat plus tablet is excreted in human breast milk, so breastfeeding women should consult a healthcare provider before taking this medication.
• Alcohol: Drinking alcohol while taking Hepcinat plus tablet is generally not recommended. Alcohol can have negative effects on the liver, which can exacerbate the effects of hepatitis C.
• Liver: Hepcinat plus tablets are primarily used to treat hepatitis C. Patients having other liver ideas should consult a doctor before taking them.
• Lungs: Patients should consult a healthcare provider with any pre-existing lung conditions with their healthcare provider before starting treatment with Hepcinat plus tablet.
• Driving: Patients should always monitor their response to the Hepcinat plus tablet medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
• Pregnancy: The safety of Hepcinat plus tablet during pregnancy is not well-established. Pregnant women should consult their healthcare provider about their pregnancy status before receiving this medication.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.